Rosemarie Corrigan Frqa Frsb

Rosemarie Corrigan has a diverse background in quality assurance and compliance in the pharmaceutical industry. Rosemarie currently serves as the Executive Vice President Global Quality at Worldwide Clinical Trials. Prior to this, they were the Chief Quality Officer at Nordic Nanovector ASA and held various roles at ThromboGenics NV, including Global Head of QA and Data Protection Officer. Rosemarie also served as the Vice President of Global Quality at Norgine, where they led quality efforts for development, manufacturing, and supply of pharma and device products. Earlier in their career, Rosemarie held positions at Stiefel (a GSK company), IQVIA, Innovex, and Syntex/Roche Pharmaceuticals, where they oversaw global QA operations and managed audits for clinical studies. Rosemarie is an active member of the Research Quality Association (RQA) and has chaired its GCP Committee since 2021.

Rosemarie Corrigan FRQA FRSB holds a Bachelor of Science (BSc) degree in Biochemistry from the University of Galway. Rosemarie also has a Diploma in Research Quality Assurance from Anglia Ruskin University. In 2019, they pursued further education at St Mary's University, Twickenham, where they completed a Master of Arts (MA) in Bioethics & Medical Law.